Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation

British Journal of Anaesthesia

Volumn 109, Issue 4, 2012, Pages 572-577

  Schaden, E ^a   Wetzel, L ^a   Kozek Langenecker, S ^a,b   Thaler, U ^a   Scharbert, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Anaesthetics and Intensive Care   (Austria)

Author keywords

Blood; coagulation; Diagnostic techniques and procedures; Hydroxylethyl starch; Isotonic solutions; platelet function test; thrombelastography

Indexed keywords

ADENOSINE DIPHOSPHATE; CHLORIDE; HETASTARCH; SODIUM CHLORIDE; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; MALE; MULTIPLE ELECTRODE AGGREGOMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ROTATIONAL THROMBELASTOMETRY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 84866390562     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes229     Document Type: Article

References (33)

1. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2011; 3: CD001319
2. Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary plateletmediated hemostasis and clot formation. Anesth Analg 2002; 95: 858-65
3. Fries D, Krismer A, Klingler A, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth 2005; 95: 172-7 (Pubitemid 41487140)
4. Stögermüller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91: 823-7
5. Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92: 1402-7 (Pubitemid 32493149)
6. Deusch E, Gamsjäger T, Kress HG, Kozek-Langenecker SA. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003; 97: 680-3 (Pubitemid 37046426)
7. Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99: 665-8 (Pubitemid 39100348)
8. Kozek-Langenecker SA. Benefits of fluid therapy on the hemostatic system of intensive care patients. J Coagul Disord 2010; 2: 41-8
9. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-60 (Pubitemid 41243429)
10. Guidet B, Soni N, Della Rocca G, et al. A balanced view of balanced solutions. Crit Care 2010; 14: 325
11. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009; 22: 267-74
12. Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth 2010; 105: 273-81
13. Roche AM, James MF, Grocott MP, Mythen MG. Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution. Anaesthesia 2002; 57: 950-5 (Pubitemid 35203324)
14. Kulla M, Lampl L, Weidhase R. Hydroxyethyl starch 6% 130/0.42 in acetate-buffered Ringer's solution as a part of a balancedvolume resuscitation in abdominal surgery. Anästhesiol Intensivmed 2008; 1: 7-18 (Pubitemid 351194871)
15. Scharbert G, Kozek-Langenecker S. Limitations of in vitro experiments on hydroxyethyl starch solutions. Anesth Analg 2007; 105: 885 (Pubitemid 47300896)
16. Pfanner G, Koscielny J, Pernerstorfer T, et al.; Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Anaesthesist 2007; 56: 604-11 (Pubitemid 46985728)
17. Kang JG, Ahn HJ, Kim GS, et al. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4). Anesth Analg 2006; 103: 1543-8 (Pubitemid 44949227)
18. Feuring M, Christ M, Roell A, et al. Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis 2002; 13: 443-7 (Pubitemid 35001861)
19. Roell A, Schueller P, Schultz A, et al. Effect of oral contraceptives and ovarian cycle on platelet function. Platelets 2007; 18: 65-70
20. Calatzis A, Wittwer M, Krueger B. A new approach to platelet function analysis in whole blood: the multiplate analyzer. Platelets 2004; 15: 485-6
21. Lang T, Bauters A, Braun SL, et al. Multi-centre investigation on reference ranges for ROTEM thrombelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10 (Pubitemid 40705054)
22. Theusinger OM, Nürnberg J, Asmis LM, Seifert B, Spahn DR. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg 2010; 37: 677-83
23. Hanke AA, Roberg K, Monaca E, et al. Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate). Eur J Med Res 2010; 15: 214-9
24. Base EM, Standl T, Lassnigg A, et al. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery. J Cardiothorac Vasc Anesth 2011; 25: 407-14
25. Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94: 1280-7 (Pubitemid 34441851)
26. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry guided coagulation factor concentratebased therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83
27. Available from http://www.oegari.at/web-files/dateiarchiv/116/key messages management of TIC 2011.pdf (accessed 6 January 2012)
28. Fries D, Innerhofer P, Reif C, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006; 102: 347-51 (Pubitemid 43152574)
29. Nielsen VG. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. J Heart Lung Transplant 2006; 25: 1344-52 (Pubitemid 44696322)
30. Mittermayr M, Streif W, Haas T, et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008; 100: 307-14 (Pubitemid 351773636)
31. Sibbing D, Morath T, Braun S, et al. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010; 103: 151-9
32. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008; 109: 723-40
33. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100: 1576-83 (Pubitemid 40712703)